September 8, 2020

Five African-American researchers and healthcare professionals on UC’s medical campus have received sizable grants from the National Institutes of Health during the past 18 months. The faculty members were interviewed by WCPO to help showcase innovation and the diverse voices and perspectives they bring as the healthcare community attempts to ease health disparities in communities of color in Cincinnati and beyond.

April 16, 2020

August 4, 2021

UC researchers launched a new study looking treating a common brain problem that results after therapy for cancer.

August 17, 2020

UC researchers from the College of Medicine and DAAP are working together to see how a music app may help patients who experience "chemobrain."

August 27, 2021

UC research examining a music app to help breast cancer survivors is mentioned by Forbes.

September 23, 2022

The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.

May 29, 2024

University of Cincinnati Cancer Center experts will present research on ovarian and blood cancer trials, the link between poor sleep and cancer-related cognitive impairment, and an innovative youth education program at the American Society of Clinical Oncology annual meeting 2024 in Chicago.

May 18, 2021

UC's Daniel Pomeranz Krummel, PhD, discusses new brain cancer research with Liz Bonis on Local 12's What's Happening in Health program.

May 7, 2021

Researchers at the University of Cincinnati, in collaboration with the Georgia Institute of Technology and Emory University, have found that using ultrasound combined with RNA-loaded nanoparticles could help infiltrate the blood-brain barrier and deliver targeted, more effective treatment to brain tumors, while eliminating uncomfortable side effects.

January 8, 2021

Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health, learned he received the placebo in the Moderna vaccine clinical trial. He then received the real vaccine to show that he believes in the science.